Good read, it was further confirmed again in an announcement by...

Good read, it was further confirmed again in an announcement by the company in October which is the last update we have had:

Outlook for the 2017 financial year Commenting on RXP’s outlook for FY17 and beyond, Mr Fielding said: “We have made a strong start to the 2017 financial year, and are expecting to deliver at the top end of our revenue growth guidance of 10-15%, and maintain a target EBITDA margin of 13-14%. “With an enhanced capability set and the One-RXP strategy deeply entrenched in our culture, we expect to see continued cross-practice growth in client work. We are seeing a growing level of spend in our sector as clients look to leverage design thinking and new technologies to help them grow their businesses which is helping to drive a strong pipeline of work across our specialist practices. “With a strong balance sheet in place and growing cashflow conversion, we continue to be very well placed to participate in industry consolidation. “Given the healthy outlook and strong financial position, our progressive dividend policy remains in place. We look forward to continuing to deliver excellent outcomes for our people, clients, partners, and our shareholders.”

There is also a more recently article published by them highlighting RXP as an attractive buy.
http://www.fool.com.au/2017/01/25/10-explosive-growth-shares-at-the-top-of-my-shopping-list/